Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Baird

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Reproductive Biomedicine Online|March 14, 2009
Emergency contraception: how does it work?David T Baird
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 4, 2002
Medical abortion in the first trimesterDavid T Baird
BJOG : an International Journal of Obstetrics and Gynaecology|November 28, 2002
A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancyJulia Bartley, David T Baird
Acta Obstetricia Et Gynecologica Scandinavica|February 7, 2019
The development of ovarian tissue cryopreservation in Edinburgh: Translation from a rodent model through validation in a large mammal and then into clinical practiceRichard A Anderson, David T Baird
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 daysAudrey Brown, Linan Cheng, Suiqing Lin, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 26, 2004
Long-term ovarian function in sheep after ovariectomy and autotransplantation of cryopreserved cortical stripsDavid T Baird, Bruce Campbell, Carlos de Souza, et al.
Endocrinology|December 20, 2003
Evidence of a role for follicle-stimulating hormone in controlling the rate of preantral follicle development in sheepBruce K Campbell, Evelyn E Telfer, Robert Webb, et al.
Human Reproduction (Oxford, England)|June 30, 2006
Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factorNitish Narvekar, Hilary O D Critchley, Linan Cheng, et al.
Contraception|October 17, 2003
A single dose of mifepristone (200 mg) in the immediate preovulatory phase offers contraceptive potential without cycle disruptionAudrey Brown, Alistair Williams, Sharon Cameron, et al.
Fertility and Sterility|February 6, 2003
A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatmentPeter Y K Yong, Sandra Brett, David T Baird, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Reproductive Biomedicine Online|March 14, 2009
Emergency contraception: how does it work?David T Baird
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 4, 2002
Medical abortion in the first trimesterDavid T Baird
BJOG : an International Journal of Obstetrics and Gynaecology|November 28, 2002
A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancyJulia Bartley, David T Baird
Acta Obstetricia Et Gynecologica Scandinavica|February 7, 2019
The development of ovarian tissue cryopreservation in Edinburgh: Translation from a rodent model through validation in a large mammal and then into clinical practiceRichard A Anderson, David T Baird
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 daysAudrey Brown, Linan Cheng, Suiqing Lin, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 26, 2004
Long-term ovarian function in sheep after ovariectomy and autotransplantation of cryopreserved cortical stripsDavid T Baird, Bruce Campbell, Carlos de Souza, et al.
Endocrinology|December 20, 2003
Evidence of a role for follicle-stimulating hormone in controlling the rate of preantral follicle development in sheepBruce K Campbell, Evelyn E Telfer, Robert Webb, et al.
Human Reproduction (Oxford, England)|June 30, 2006
Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factorNitish Narvekar, Hilary O D Critchley, Linan Cheng, et al.
Contraception|October 17, 2003
A single dose of mifepristone (200 mg) in the immediate preovulatory phase offers contraceptive potential without cycle disruptionAudrey Brown, Alistair Williams, Sharon Cameron, et al.
Fertility and Sterility|February 6, 2003
A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatmentPeter Y K Yong, Sandra Brett, David T Baird, et al.
Pageof 4